46 Results for "

Sustained release

" in MedChemExpress (MCE) Product Catalog:
Products (46)

46 Results for "Sustained release" in MCE Product Catalog:

Cat. No.: HY-189072
Research Areas:  

Others

Insecticidal agent 39 (compound I ai) is a potent insecticide that targets Ryanodine Receptor (RyR). The LC50 of Insecticidal agent 39 against M. separata is 0.26 mg/L. Insecticidal agent 39 specifically binds to and activates RyR, inducing the release of Ca 2+ from the sarcoplasmic reticulum into the cytoplasm, which leads to sustained muscle contraction and eventual paralysis and death of the pest. Insecticidal agent 39 can be used in studies related to lepidopteran pest infestation .
loading...
    loading...
Cat. No.: HY-184601
Glycyrrhizic acid (GA) is a saponin derived from the root of the traditional Chinese medicine licorice. It possesses various pharmacological effects, such as anti-inflammatory, antioxidant, immunomodulatory, and antiviral activity. In addition to its own pharmacological activity, GA can form complexes with many drugs and other natural products. Structurally, glycyrrhizic acid is an amphiphilic molecule; its hydrophilic portion consists of glucuronic acid residues, while its hydrophobic portion is composed of glycyrrhizic acid residues. It can aggregate in water to form self-assembled micelles. Glycyrrhizic acid encapsulates hydrophobic drugs through self-assembly into host-guest complexes, thereby increasing drug solubility and inhibiting precipitation. These complexes can also achieve sustained and controlled release of encapsulated drugs. Therefore, glycyrrhizic acid micelles can serve as drug carriers to improve the absorption of hydrophobic drugs.
loading...
    loading...
Cat. No.: HY-W127512R
CAS No.: 546-18-9
Research Areas:  

Others

5β-Cholanic acid is a hydrophobic modifier used to modify polymer carriers. 5β-Cholanic acid can improve the acid stability, cell penetration efficiency and drug sustained release ability of nanocarriers, and optimize the oral effectiveness of delivered molecules. 5β-Cholanic acid can covalently bind to Glycol chitosan (GC) to form a GC-CA conjugate, which optimizes the hydrophobic anchoring ability of nanoparticles and enables them to be stably adsorbed on the surface of PLGA nanoparticles. Such nanoparticles can resist dissociation in the gastric acid environment and maintain positive charge to enhance endocytic uptake by intestinal epithelial cells (such as Caco-2 cells). 5β-Cholanic acid can be used in the development of drug delivery systems .
loading...
    loading...
Cat. No.: HY-184378
CAS No.: 2922221-22-3
Research Areas:  

Metabolic Disease Cancer

MDB5 is a Hedgehog pathway and Smoothened inhibitor that binds to the 7-TM domain of Smo . MDB5 reduces hepatic stellate cell activation, extracellular matrix-related gene expression, collagen deposition, hydroxyproline content and epithelial-mesenchymal transition, and prevents sinusoidal endothelial cell capillarization . MDB5 induces G1 and S phase cell cycle arrest, triggers apoptosis by upregulating Bax and downregulating Bcl-2, and also decreases oxygen consumption rate, glucose uptake, transglutaminase activity and fibronectin matrix assembly . MDB5 reduces the levels of liver injury markers, hepatic triglyceride deposition and hepatic steatosis, restores the tissue structure of the kidney and spleen, and inhibits pancreatic tumor growth without causing body weight loss . MDB5 can be loaded into PEG-PCC-g-DC micelles, achieving high drug loading, sustained release, improved water solubility, enhanced cellular uptake and optimized hepatic distribution, with good tolerance in mice . MDB5 is applicable to research related to alcohol-associated liver disease, liver fibrosis and pancreatic cancer .
loading...
    loading...